Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to describe patient characteristics and drug usage among patients
that are prescribed ticagrelor for the first time and to compare them with patients who are
prescribed clopidogrel and prasugrel for the first time.
A further purpose is to ascertain and estimate the crude incidence rate of bleeding,
arrhythmias, heart failure, acute renal failure, acute liver failure, dyspnoea and gout among
new users in the three cohorts of ticagrelor, clopidogrel and prasugrel.